Activation of caspase 3 resulting from the effect of PLGA–apigenin nanoparticles on human skin cancer cells confirms the superior apoptotic activity of apigenin-loaded nanoparticles compared to that of apigenin [30]. The gene discussed is CASP3; the disease is skin cancer.